HighTower Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
59,422
+12,643
| +27% | +$64K | ﹤0.01% | 2920 |
|
|
2025
Q1 | $247K | Sell |
46,779
-75,991
| -62% | -$402K | ﹤0.01% | 3003 |
|
|
2024
Q4 | $830K | Buy |
122,770
+98,626
| +408% | +$667K | ﹤0.01% | 2089 |
|
|
2024
Q3 | $159K | Sell |
24,144
-7,040
| -23% | -$46.4K | ﹤0.01% | 3189 |
|
|
2024
Q2 | $233K | Buy |
31,184
+18,002
| +137% | +$135K | ﹤0.01% | 2905 |
|
|
2024
Q1 | $129K | Buy |
+13,182
| New | +$129K | ﹤0.01% | 3063 |
|